Stock Sale, Buyback News

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s Board of Directors approved the grant, effective January 5th, 2026, to three non-executive employees of non-qualified stock...

SAN MATEO, Calif.--(BUSINESS WIRE)--Guidewire (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced that it has completed its share repurchase program previously authorized in September 2022 and that, effective immediately, its board of directors has approved a new share repurchase program with authorization to purchase up to $500.0 million of its outstanding shares of common stock. Repurchases under the new program may be made in th...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--RiverNorth Capital and Income Fund, Inc. (the “Fund”) (NYSE: RSF), a closed-end fund, announced the final results of its repurchase offer for up to 5% of its outstanding common shares. The repurchase offer expired at 5:00 P.M. Eastern Time on January 7, 2026. Based on information provided by DST Systems, Inc., the depositary for the repurchase offer, a total of 1,208,418 shares were submitted for redemption and 201,763 shares were repurchased. In accordan...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 93,000 shares of common stock to three new employees under the Company’s 2024 Indu...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qualified stock options to purchase an aggregate of 16,650 shares of the company’s common stock to one new employee (the “In...

GREENWICH, Conn.--(BUSINESS WIRE)--W. R. Berkley Corporation (NYSE: WRB) announced today that its Board of Directors has increased the Company's share repurchase authorization to 25 million shares of common stock. The Company’s focus continues to be on delivering value to shareholders through building book value as well as returning excess capital to shareholders through a variety of available methods. Repurchases may be made by the Company from time to time at prevailing prices in the open mar...

WAYZATA, Minn.--(BUSINESS WIRE)--SUI Group Holdings Limited (NASDAQ: SUIG) (“SUI Group,” “SUIG” or the “Company”) today provided an update that as of January 7, 2026, its total SUI holdings increased to 108,098,436, primarily driven by lending activities in SUI ecosystem and native staking rewards. In addition, during the fourth quarter of 2025, the Company repurchased 7,801,042 shares of its common stock under its previously authorized $50 million stock repurchase program at an average purchas...

TORONTO--(BUSINESS WIRE)--Largo Announces US$60 Million At-The-Market Equity Offering Program...

OTTAWA, Ontario--(BUSINESS WIRE)--Edgewater Wireless Systems Inc. (TSX-V: YFI) (OTC: KPIFF) (the “Company” or “Edgewater Wireless”) announces its shareholders have approved the Company’s new equity incentive plan (the “Compensation Plan”) at the annual meeting of shareholders held on December 10, 2025 (the “Shareholders’ Meeting”). The Compensation Plan supersedes the Company’s 2024 fixed 20% stock option plan. The Compensation Plan provides the Company with the ability to issue stock options (...

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported inducement awards granted to December 2025 new hires, in accordance with Nasdaq Listing Rule 5635(c)(4)....